Research course

Pharmacology

Institution
The University of Manchester · Faculty of Biology, Medicine and Health
Qualifications
PhDMPhil

Visit the institution website for COVID‑19 updates

Entry requirements

We require applicants to hold, or be about to obtain, an Upper Second class Honours degree (or overseas equivalent) in a related subject area for entry to a PhD programme. A Lower Second class Honours degree may be considered if applicants also hold a Master's degree with a Merit classification.

Months of entry

January, April, September

Course content

Our PhD/MPhil Pharmacology programme enables you to undertake a research project that will improve understanding of Pharmacology.

Our pharmacology research focuses on a range of topics. These include:

  • The pharmacology of drug efflux transporters, particularly ABCB1 P-glycoprotein, ABCG2 breast cancer resistance protein and ABCC multidrug resistance-associated transporters;
  • Developing complex, physiologically-relevant in vitro cell systems to investigate transport, metabolism and delivery of therapeutic drugs;
  • Understanding the pharmacological and molecular mechanisms that regulate expression and function of drug efflux transporters, particularly in the blood-brain barrier;
  • The role of blood-brain barrier drug efflux transporters in drug delivery to the central nervous system and the effects of inflammatory and degenerative conditions, e.g. Alzheimer's disease, on efflux transporter function;
  • The biological role of lipid networks in health and disease, particularly their roles in inflammation, cellular communications and tissue responses;
  • Employing mass spectrometry-based lipidomic technology, in conjunction with functional, metabolic and signalling approaches to characterise lipid profiles in physiological and pathophysiological conditions;
  • Investigating the role of lipids in skin homeostasis and in response to inflammation, injury and wound healing;
  • Studying role of local hormones in diseases and conditions associated with the female reproductive tract (e.g. dysmenorrhoea, endometriosis and the detection and prevention of preterm labour);
  • Molecularly identifying and pharmacologically characterising receptors expressed in the female reproductive system;
  • Understanding the physiological and pharmacological characteristics of the placenta. These studies include the development of placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of placental growth signalling.

Qualification, course duration and attendance options

  • PhD
    full time
    36-48 months
    • Campus-based learningis available for this qualification
    part time
    72-96 months
    • Campus-based learningis available for this qualification
  • MPhil
    part time
    24 months
    • Campus-based learningis available for this qualification
    full time
    12 months
    • Campus-based learningis available for this qualification

Course contact details

Name
Faculty of Biology, Medicine and Health
Email
admissions.doctoralacademy@manchester.ac.uk
Phone
+44 (0)161 275 5608